Skip to main content

Closed

PLSE: Pulse Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Medical - Instruments & Supplies

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-10392.1%

ROIC-106.3%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage0.0×

Current ratio7.26×

Pulse Biosciences, Inc.

PLSENASDAQ Capital Market·USD·Closed

Pulse Biosciences, Inc.

PLSENASDAQ·USD·Closed

$35.13

+0.26%

$35.13

+$0.09 (0.26%)

52W Range

93thpctl

Volume

0.73×avg

Mkt Cap

2.43BUSD

P/E

-32.2TTM

Div Yield

–ann

52W Range

93thpctl

Volume

0.73×avg

Market Cap

2.43BUSD

P/E Ratio

-32.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings